Chemoinformaics analysis of 2-HEXYLDECAN-1-OL
Molecular Weight | 242.447 | nRot | 13 |
Heavy Atom Molecular Weight | 208.175 | nRig | 7 |
Exact Molecular Weight | 242.261 | nRing | 0 |
Solubility: LogS | -2.419 | nHRing | 0 |
Solubility: LogP | 2.644 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 50.193 |
nHD | 1 | BPOL | 34.109 |
QED | 0.64 |
Synth | 1.427 |
Natural Product Likeliness | -0.209 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.002 |
HIA | 0.003 |
CACO-2 | -4.288 |
MDCK | 0.0000495 |
BBB | 0.721 |
PPB | 0.824659 |
VDSS | 1.332 |
FU | 0.173519 |
CYP1A2-inh | 0.971 |
CYP1A2-sub | 0.178 |
CYP2c19-inh | 0.859 |
CYP2c19-sub | 0.238 |
CYP2c9-inh | 0.195 |
CYP2c9-sub | 0.149 |
CYP2d6-inh | 0.035 |
CYP2d6-sub | 0.18 |
CYP3a4-inh | 0.023 |
CYP3a4-sub | 0.377 |
CL | 13.337 |
T12 | 0.891 |
hERG | 0.114 |
Ames | 0.065 |
ROA | 0.035 |
SkinSen | 0.535 |
Carcinogencity | 0.341 |
EI | 0.959 |
Respiratory | 0.038 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.697274 |